Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery

被引:4
|
作者
Ma, Guanchen [1 ,2 ]
Zeng, Shaoqing [1 ,2 ]
Zhao, Yingjun [1 ,2 ]
Chi, Jianhua [1 ,2 ]
Wang, Li [3 ]
Li, Qingshui [4 ]
Wang, Jing [5 ]
Yao, Shuzhong [6 ]
Zhou, Qi [7 ]
Chen, Youguo [8 ]
Jiao, Xiaofei [1 ,2 ]
Liu, Xingyu [1 ,2 ]
Yu, Yang [1 ,2 ]
Huo, Yabing [1 ,2 ]
Li, Ming [1 ,2 ]
Peng, Zikun [1 ,2 ]
Ma, Ding [1 ,2 ]
Hu, Ting [1 ,2 ]
Gao, Qinglei [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gynecol Oncol, 1095 Jiefang Ave, Wuhan 430000, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Key Lab Minist Educ,Canc Biol Res Ctr,Natl Clin Re, Wuhan, Peoples R China
[3] Zhengzhou Univ, Canc Hosp, Henan Tumor Hosp, Dept Gynecol, Zhengzhou, Peoples R China
[4] Shandong Canc Hosp & Inst, Dept Gynecol Oncol, Jinan, Shandong, Peoples R China
[5] Cent South Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Xiangya Sch Med, Changsha, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, 58,2nd Zhongshan Rd, Guangzhou 510080, Peoples R China
[7] Chongqing Canc Hosp, Dept Gynecol Oncol, Chongqing 400030, Peoples R China
[8] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou 215123, Peoples R China
基金
美国国家科学基金会;
关键词
Mucinous ovarian cancer; Nomogram; Cancer-specific survival; SEER database; RESIDUAL DISEASE;
D O I
10.1186/s13048-023-01213-2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BackgroundMucinous epithelial ovarian cancer (mEOC) is a relatively uncommon subtype of ovarian cancer with special prognostic features, but there is insufficient research in this area. This study aimed to develop a nomogram for the cancer-specific survival (CSS) of mEOC based on Surveillance, Epidemiology, and End Results (SEER) database and externally validate it in National Union of Real World Gynecological Oncology Research and Patient Management (NUWA) platform from China.MethodsPatients screened from SEER database were allocated into training and internal validation cohort in a ratio of 7: 3, with those from NUWA platform as an external validation cohort. Significant factors selected by Cox proportional hazard regression were applied to establish a nomogram for 3-year and 5-year CSS. The performance of nomogram was assessed by concordance index, calibration curves and Kaplan-Meier (K-M) curves.ResultsThe training cohort (n = 572) and internal validation cohort (n = 246) were filtered out from SEER database. The external validation cohort contained 186 patients. Baseline age, tumor stage, histopathological grade, lymph node metastasis and residual disease after primary surgery were significant risk factors (p < 0.05) and were included to develop the nomogram. The C-index of nomogram in training, internal validation and external validation cohort were 0.869 (95% confidence interval [CI], 0.838-0.900), 0.839 (95% CI, 0.787-0.891) and 0.800 (95% CI, 0.738-0.862), respectively. The calibration curves of 3-year and 5-year CSS in each cohort showed favorable agreement between prediction and observation. K-M curves of different risk groups displayed great discrimination.ConclusionThe discrimination and goodness of fit of the nomogram indicated its satisfactory predictive value for the CSS of mEOC in SEER database and external validation in China, which implies its potential application in different populations.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery
    Guanchen Ma
    Shaoqing Zeng
    Yingjun Zhao
    Jianhua Chi
    Li Wang
    Qingshui Li
    Jing Wang
    Shuzhong Yao
    Qi Zhou
    Youguo Chen
    Xiaofei Jiao
    Xingyu Liu
    Yang Yu
    Yabing Huo
    Ming Li
    Zikun Peng
    Ding Ma
    Ting Hu
    Qinglei Gao
    Journal of Ovarian Research, 16
  • [2] A nomogram to predict the cancer-specific survival of stage II-IV Epithelial ovarian cancer after bulking surgery and chemotherapy
    Zhao, Ling
    Yu, Ping
    Zhang, Li
    CANCER MEDICINE, 2021, 10 (13): : 4344 - 4355
  • [3] Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma
    Qiaozhu Zeng
    Yuou Yao
    Mingwei Zhao
    BMC Ophthalmology, 21
  • [4] Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma
    Zeng, Qiaozhu
    Yao, Yuou
    Zhao, Mingwei
    BMC OPHTHALMOLOGY, 2021, 21 (01)
  • [5] Development and Validation of a Prognostic Nomogram to Predict Cancer-Specific Survival in Adult Patients With Pineoblastoma
    Jing, Yajun
    Deng, Wenshuai
    Zhang, Huawei
    Jiang, Yunxia
    Dong, Zuoxiang
    Fan, Fan
    Sun, Peng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer
    Zhang, Zhaoxia
    Cai, Qian
    Wang, Jinkui
    Yao, Zhigang
    Ji, Fengming
    Hang, Yu
    Ma, Jing
    Jiang, Hongchao
    Yan, Bing
    Zhanghuang, Chenghao
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [7] Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer
    Zhaoxia Zhang
    Qian Cai
    Jinkui Wang
    Zhigang Yao
    Fengming Ji
    Yu Hang
    Jing Ma
    Hongchao Jiang
    Bing Yan
    Chenghao Zhanghuang
    Scientific Reports, 13
  • [8] Development and validation of a nomogram to predict long-term cancer-specific survival for patients with osteosarcoma
    Yali Yu
    Shaohua Wang
    Jia Liu
    Jiejie Ge
    Hongya Guan
    Scientific Reports, 13
  • [9] Development and validation of a nomogram to predict long-term cancer-specific survival for patients with osteosarcoma
    Yu, Yali
    Wang, Shaohua
    Liu, Jia
    Ge, Jiejie
    Guan, Hongya
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] Development and validation of a nomogram to predict cancer-specific survival with unresected cholangiocarcinoma undergoing external radiotherapy
    Song, Jiazhao
    Di, Yupeng
    Kang, Xiaoli
    Ren, Gang
    Wang, Yingjie
    FRONTIERS IN PUBLIC HEALTH, 2023, 11